Journal of Kerman University of Medical Sciences

The Effects of Methanolic Extract of Prosopis Farcta Seed on Blood Glucose in Streptozocin Induced Diabetic Rats

Document Type : Original Article

Authors

Sahel Heidar Lashkari Heidar Lashkari 1
Gholamreza Sepehri 2
Ladan Emadi 3
Sahel Motaghi 3

1 Doctor of Veterinary Medicine, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran

2 Professor of Pharmacology, Kerman Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran

3 Assistant Professor of Veterinary Physiology, Department of Physiology, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran

Abstract
Background: Previous studies have shown the beneficial effects of Prosopis species in the treatment of diabetes in traditional medicine. This study was performed to evaluate the antihyperglycemic effects of Prosopis farcta (P.farcta) in streptozocin- induced diabetic rats.
Methods: Diabetes was induced by intraperitoneal injection of streptozocin (55mg/kg). Male Wistar rats were treated with either P. farcta (100, 150, and 300 mg/kg.) or glibenclamide (10mg/kg) orally once a day for a period of 28 days. Control rats received saline. Changes in body weight and blood glucose were measured at the end of each week for 4 weeks.
Results: The results of this study showed a significant increase in blood glucose, and decrease of body weight in streptozocin-induced diabetic rats. P. farcta administration for 28 days in streptozocin-induced diabetic rats suppressed the weight reduction significantly in a dose dependent manner (p <0.001). Also, P. farcta, like glibenclamide, showed significant antihyperglycemic effects and reversed the above parameters significantly in a dose dependent manner when compared to diabetic control rats (p <0.001, p <0.05, respectively).
Conclusions: The results of the present study showed that P. farcta possesses antidiabetic activity in hyperglycemic rat models. The underlying mechanism(s) has not been known yet and needs further investigation.

Keywords

Blood glucose
Diabetes
Prosopis Farcta
Streptozocin
Rat
  1. World Health Organization. Diabetes Action Now: An Initiative of the World Health Organization and the International Diabetes Federation. Switzerland: World Health Organization; 2004
  2. Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S, et al. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005–2011. Diabetes research and clinical practice. 2014; 103(2):319-27.
  3. Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, et al. Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC public health. 2009; 9(1):167.
  4. Najafipour H, Mirzazadeh A, Haghdoost A-A, Shadkam M, Afshari M, Moazenzadeh M, et al. Coronary artery disease risk factors in an urban and peri-urban setting, Kerman, Southeastern Iran (KERCADR study): methodology and preliminary report. Iranian journal of public health. 2012; 41(9):86.
  5. Najafipour H, Sanjari M, Shokoohi M, Haghdoost AA, Afshari M, Shadkam M, et al. Epidemiology of diabetes mellitus, pre‐diabetes, undiagnosed and uncontrolled diabetes and its predictors in general population aged 15 to 75 years: A community‐based study (KERCADRS) in southeastern Iran. Journal of diabetes. 2015; 7(5):613-21.
  6. Kennedy MSN, Masharani U. Pancreatic Hormones & Antidiabetic Drugs. In: BG K, editor. Basic & Clinical Pharmacology. 13 ed. Newyork: Lange Medical Books/McGraw-Hill; 2015. p. 723-47.
  7. Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clinical Science. 2005; 109(2):143-59.
  8. Schiavoni M, Cosentino F, Camici GG, Luescher TF. Diabetes and Endothelial Dysfunction. High Blood Pressure & Cardiovascular Prevention. 2007; 14(1):5-10.
  9. Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocrine reviews. 2001; 22(1):36-52.
  10. Gholamhoseinian A, Fallah H, Sharifi-far F, Mirtajaddini M. The inhibitory effect of some Iranian plants extracts on the alpha glucosidase. Iranian Journal of Basic Medical Sciences. 2008; 11(1):1-9.
  11. Sepehri G, Khaksari M, Najar AG. The effect of water extract of Zataria multiflora on microvascular permeability in streptozocin induced diabetic rats. Annual Research & Review in Biology. 2014; 4(20):3119.
  12. Baharvand-Ahmadi B, Bahmani M, Tajeddini P, Naghdi N, Rafieian-Kopaei M. An ethno-medicinal study of medicinal plants used for the treatment of diabetes. Journal of nephropathology. 2016; 5(1):44.
  13. Ayyanar M, Sankarasivaraman K, Ignacimuthu S. Traditional herbal medicines used for the treatment of diabetes among two major tribal groups in south Tamil Nadu, India. Ethnobotanical leaflets. 2008; 2008(1):32.
  14. Malviya N, Jain S, Malviya S. Antidiabetic potential of medicinal plants. Acta Pol Pharm. 2010; 67(2):113-8.
  15. Okyar A, Can A, Akev N, Baktir G, Sütlüpinar N. Effect of Aloe vera leaves on blood glucose level in type I and type II diabetic rat models. Phytotherapy Research. 2001; 15(2):157-61.
  16. Mohammadi A, Gholamhoseinian A, Fallah H. Zataria multiflora increases insulin sensitivity and PPARγ gene expression in high fructose fed insulin resistant rats. Iranian Journal of Basic Medical Sciences. 2014; 17(4):263-70.
  17. Leakey R, Last F. Biology and potential of Prosopis species in arid environments, with particular reference to P. cineraria. J Arid Environ; (United States). 1980; 3(1).
  18. George C, Lochner A, Huisamen B. The efficacy of Prosopis glandulosa as antidiabetic treatment in rat models of diabetes and insulin resistance. J Ethnopharmacol. 2011 Sep 1; 137(1):298-304.
  19. Campuzano-Bublitz MA, Ibarrola DA, Hellión-Ibarrola MC, Dölz JH, Kennedy ML. Acute and Chronic anti-hyperglycemic effect of Prosopis ruscifolia extract in Normoglycemic and Alloxan-Induced Hyperglycemic Rats. Journal of Applied Pharmaceutical Science Vol. 2016; 6(05):178-84.
  20. Sharma N, Garg V, Paul A. Antihyperglycemic, antihyperlipidemic and antioxidative potential of Prosopis cineraria bark. Indian Journal of Clinical Biochemistry. 2010; 25(2):193-200.
  21. Asadollahi K, Abassi N, Afshar N, Alipour M, Asadollahi P. Investigation of the effects of prosopis farcta plant extract on Rat's aorta. J Med Plants Res. 2009; 4(2):142-7.
  22. Asadollahi A, Sarir H, Omidi A, Torbati MBM. Hepatoprotective potential of Prosopis farcta beans extracts against acetaminophen induced hepatotoxicity in Wistar Rats. International journal of preventive medicine. 2014; 5(10).
  23. Miri A, Sarani M, Bazaz MR, Darroudi M. Plant-mediated biosynthesis of silver nanoparticles using Prosopis farcta extract and its antibacterial properties. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2015; 141:287-91.
  24. Souri E, Amin G, Farsam H. Screening of antioxidant activity and phenolic content of 24 medicinal plant extracts. DARU Journal of Pharmaceutical Sciences. 2008; 16(2):83-7.
  25. Sabitha V, Ramachandran S, Naveen KR, Panneerselvam K. Antidiabetic and antihyperlipidemic potential of Abelmoschus esculentus (L.) Moench. in streptozotocin-induced diabetic rats. J Pharm Bioallied Sci. 2011 Jul; 3(3):397-402.
  26. Tanko Y, Yerima M, Mahdi M, Yaro A, Musa K, Mohammed A. Hypoglycemic Activity of Methanolic Stem Bark of Adansonnia digitata Extract on Blood Glucose Levels of Streptozocin-Induced Diabetic Wistar Rats. International Journal of Applied Research in Natural Products. 2008; 1(2):32-6.
  27. Rao BK, Kesavulu M, Apparao C. Antihyperglycemic activity of Momordica cymbalaria in alloxan diabetic rats. Journal of Ethnopharmacology. 2001; 78(1):67-71.
  28. Trivedi N, Mazumdar B, Bhatt J, Hemavathi K. Effect of shilajit on blood glucose and lipid profile in alloxaninduced diabetic rats. 2004.
  29. Dashtban M, Sarir H, Omidi A. The effect of Prosopis farcta beans extract on blood biochemical parameters in streptozotocin-induced diabetic male rats. Advanced Biomedical Research. 2016; 5.
  30. Katzung B, G, editor. Basic & Clinical Pharmacology. 13 ed. New York: McGraw-Hill Education; 2015.
  31. Cheng AY, Fantus IG. Oral antihyperglycemic therapy for type 2 diabetes mellitus. Canadian Medical Association Journal. 2005; 172(2):213-26.
  32. Cheng D, Liang B, Li Y. Antihyperglycemic effect of Ginkgo biloba extract in streptozotocin-induced diabetes in rats. BioMed research international. 2012; 2013.
  33. Torrico F, Cepeda M, Guerrero G, Melendez F, Blanco Z, Canelón DJ, et al. Hypoglycaemic effect of Croton cuneatus in streptozotocin-induced diabetic rats. Revista Brasileira de Farmacognosia. 2007; 17(2):166-9.
  34. Hill C. The efficacy of Diavite tm (Prosopis glandulosa) as anti-diabetic treatment in rat models of streptozotocin-induced type 1 diabetes and diet-induced-obese insulin resistance: Stellenbosch: University of Stellenbosch; 2010.
  35. Bösenberg LH, van Zyl DG. The mechanism of action of oral antidiabetic drugs: a review of recent literature. Journal of Endocrinology, Metabolism and Diabetes of South Africa. 2008; 13(3):80-8.
  36. Lamarque AL, Maestri DM, Grosso NR, Zygadlo JA, Guzmán CA. Proximate composition and seed lipid components of some Prosopis (Leguminosae) from Argentina. Journal of the Science of Food and Agriculture. 1994; 66(3):323-6.
  37. Astudillo L, Schmeda‐Hirschmann G, Herrera JP, Cortés M. Proximate composition and biological activity of Chilean Prosopis species. Journal of the Science of Food and Agriculture. 2000; 80(5):567-73.
  38. Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond). 2005; 109(2):143-59.
Journal of Kerman University of Medical Sciences
Volume 24, Issue 3
2017
Pages 200-208

Home

Editorial Board

Guide for Authors

Submit Manuscript

Guide for Reviewers

Contact Us